Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy

ClinicalTrials.gov ID: NCT02429830

Public ClinicalTrials.gov record NCT02429830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter Study of REflux Management With the LINX® System for Gastroesophageal REFlux Disease After Laparoscopic Sleeve Gastrectomy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the LINX device in patients who have previously undergone laparoscopic sleeve gastrectomy (LSG) for obesity and have chronic gastroesophageal reflux disease (GERD). The study will monitor safety and changes in reflux symptoms.

Study identification

NCT ID
NCT02429830
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Torax Medical Incorporated
Industry
Enrollment
30 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
22 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 5, 2017 (Actual)
Primary completion
Jun 8, 2021 (Actual)
Completion
Jun 8, 2021 (Actual)
Last update posted
Aug 10, 2022

2017 – 2021

United States locations

U.S. sites
12
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
Northwest Allied Bariatric & Foregut Surgery Tucson Arizona 85741 —
Mercy Health Northwest Arkansas Rogers Arkansas 72758 —
Keck Medical Center of USC Los Angeles California 90033 —
Institute of Esophageal and Reflux Surgery Englewood Colorado 80113 —
RWJBH Univ. Hospital Somerset/Advanced Surgical and Bariatrics of NJ, PA Somerset New Jersey 08873 —
Buffalo General Medical Center Buffalo New York 14203 —
Adirondack Surgical Group Saranac Lake New York 12983 —
East Carolina University Greenville North Carolina 27834 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Coastal Carolina Bariatric & Surgical Center Summerville South Carolina 29485 —
Panhandle Weight Loss Center Amarillo Texas 79106 —
Gunderson Health System La Crosse Wisconsin 54601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02429830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2022 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02429830 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →